Difficulty: Medium
Average Score: 89%
Practice
Which of the following statements about estrogens are True:
Correct answer
D
Rationale
The correct answer is D) All of the above. This statement is true because estradiol does indeed bind strongly to an ╬▒2-globulin and albumin with lower affinity. Additionally, estradiol is converted by the liver and other tissues to estrone, estriol, and their metabolites, which are excreted in the bile. Finally, estrone and estriol have lower affinity for estrogen receptors compared to estradiol.
Option A is incorrect because estradiol binds strongly to sex hormone-binding globulin, not ╬▒2-globulin. Option B is incorrect because it incorrectly states that estradiol is excreted in the bile, when in fact it is predominantly excreted in the urine. Option C is incorrect because it states that estrone and estriol have higher affinity for estrogen receptors, which is inaccurate.
Understanding the pharmacokinetics of estrogens is crucial in pharmacological lifespan treatment. Estrogens play a vital role in various physiological processes across the lifespan, including reproductive health, bone density maintenance, and cardiovascular health. Knowing how estrogens are metabolized and their affinity for receptors can help healthcare providers make informed decisions when prescribing estrogen-based therapies.
Option A is incorrect because estradiol binds strongly to sex hormone-binding globulin, not ╬▒2-globulin. Option B is incorrect because it incorrectly states that estradiol is excreted in the bile, when in fact it is predominantly excreted in the urine. Option C is incorrect because it states that estrone and estriol have higher affinity for estrogen receptors, which is inaccurate.
Understanding the pharmacokinetics of estrogens is crucial in pharmacological lifespan treatment. Estrogens play a vital role in various physiological processes across the lifespan, including reproductive health, bone density maintenance, and cardiovascular health. Knowing how estrogens are metabolized and their affinity for receptors can help healthcare providers make informed decisions when prescribing estrogen-based therapies.